Our strategy and vision

Creating opportunities for a positive future

Neuropharm is focused on helping people with unmet medical needs enjoy a better quality of life.

We describe our approach as “From Patient to Product”. This means we use our scientific and biological understanding of disorders of the central nervous system (CNS) and contacts with the patient communities, to track back to existing compounds or products that could benefit these patients.

We concentrate on selected developmental disorders where few or no existing medicines have been approved by the FDA or EMEA, and on niche markets with defined patient populations.

The group’s vision is to become the partner of choice for clinicians and patient organisations working in the field of CNS disorders, and to develop effective therapies offering significant benefits for physicians, healthcare providers and patients alike.